Previous Article | Next Article 
Journal of Virology, January 2005, p. 717-724, Vol. 79, No. 2
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.2.717-724.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies
Christiane Ruedl,
Katrin Schwarz,
Andrea Jegerlehner,
Tazio Storni,
Vania Manolova, and
Martin F. Bachmann*
Cytos Biotechnology AG, Schlieren-Zürich, Switzerland
Received 15 July 2004/
Accepted 4 August 2004
Virus-like particles (VLPs) are able to induce cytotoxic T-cell responses in the absence of infection or replication. This makes VLPs promising candidates for the development of recombinant vaccines. However, VLPs are also potent inducers of B-cell responses, and it is generally assumed that such VLP-specific antibodies interfere with the induction of protective immune responses, a phenomenon summarized as carrier suppression. In this study, we investigated the impact of preexisting VLP-specific antibodies on the induction of specific cytotoxic T-cell and Th-cell responses in mice. The data show that VLP-specific antibodies did not measurably reduce antigen presentation in vitro or in vivo. Nevertheless, T-cell priming was slightly reduced by antigen-specific antibodies; however, the overall reduction was limited and vaccination with VLPs in the presence of VLP-specific antibodies still resulted in protective T-cell responses. Thus, carrier suppression is unlikely to be a limiting factor for VLP-based T-cell vaccines.
* Corresponding author. Mailing address: Cytos Biotechnology AG, Wagistrasse 25, 8952 Schlieren-Zürich, Switzerland. Phone: 41 1 733 40 23. Fax: 41 1 733 47 04. E-mail:
martin.bachmann{at}cytos.com.
Journal of Virology, January 2005, p. 717-724, Vol. 79, No. 2
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.2.717-724.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Buonaguro, L., Tornesello, M. L., Gallo, R. C., Marincola, F. M., Lewis, G. K., Buonaguro, F. M.
(2009). Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles. J. Virol.
83: 304-313
[Abstract]
[Full Text]
-
Li, M., Bharadwaj, U., Zhang, R., Zhang, S., Mu, H., Fisher, W. E., Brunicardi, F. C., Chen, C., Yao, Q.
(2008). Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Molecular Cancer Therapeutics
7: 286-296
[Abstract]
[Full Text]
-
Ryding, J., Dahlberg, L., Wallen-Ohman, M., Dillner, J.
(2007). Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles. J. Gen. Virol.
88: 792-802
[Abstract]
[Full Text]
-
Koudelka, K. J., Rae, C. S., Gonzalez, M. J., Manchester, M.
(2007). Interaction between a 54-Kilodalton Mammalian Cell Surface Protein and Cowpea Mosaic Virus. J. Virol.
81: 1632-1640
[Abstract]
[Full Text]
-
Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L. X., Kamin-Lewis, R., Abdelwahab, S., Lewis, G. K., Buonaguro, F. M.
(2006). Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.. J. Virol.
80: 9134-9143
[Abstract]
[Full Text]